Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
et al., 2021, Leveraging genetic data to investigate the effects of interleukin-6 receptor signalling on levels of 40 circulating cytokines., Br J Clin Pharmacol
et al., 2021, Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling., Diabetologia
et al., 2021, Estimating the Population Benefits of Blood Pressure Lowering: A Wide-Angled Mendelian Randomization Study in UK Biobank., J Am Heart Assoc, Vol:10
et al., 2021, Mental Health as a Mediator of the Association Between Educational Inequality and Cardiovascular Disease: A Mendelian Randomization Study., J Am Heart Assoc, Vol:10
Sidebottom DB, Gill D, 2021, Ronapreve for prophylaxis and treatment of covid-19, Bmj-british Medical Journal, Vol:374, ISSN:1756-1833